EXPONENT INC (EXPO)
Industrials · Technical and Engineering Consulting · NASDAQ
Exponent is a premier scientific and engineering consulting firm that helps clients navigate complex product failures, safety concerns, and regulatory challenges.
What EXPONENT INC does
Exponent is a multi-disciplinary engineering and scientific consulting firm that provides solutions for complex technical, regulatory, and business problems. The company serves clients by investigating failures, assessing risks, and providing research and development support across diverse industries. Its professional staff comprises hundreds of scientists and engineers with expertise in various technical disciplines.
Themes: litigation support, product safety and reliability, industrial engineering consulting, environmental and regulatory compliance
Fundamentals
- Price$70.78 as of 2026-08-24 close
- Market cap$3.4B as of 2026-08-24
- 1-year return-2.1% 2025-08-22 close $72.29 → 2026-08-24 close $70.78
- P/E29.27 as of 2026-08-25
- Net margin+18.1% as of 2026-08-25
- Gross margin+91.4% as of 2026-08-25
- ROE+27.9% as of 2026-08-25
- Debt / equity0.00 as of 2026-08-25
- Revenue growth (YoY)+7.8% as of 2026-08-25
- Revenue CAGR (3y)+3.2% SEC XBRL
- Beta0.69 as of 2026-08-25
- Last reported earnings2026-07-30 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +1.3%; at least 2 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How EXPO compares in its sector
- price-to-earnings ratiomiddle range 351 covered Industrials peers, as of 2026-08-25
- net profit margintop 10% 457 covered Industrials peers, as of 2026-08-25
- operating margintop 25% 457 covered Industrials peers, as of 2026-08-25
- gross margintop 10% 455 covered Industrials peers, as of 2026-08-25
- return on equitytop 25% 460 covered Industrials peers, as of 2026-08-25
- 3-year revenue CAGRmiddle range 426 covered Industrials peers
- indicated dividend yieldmiddle range 267 covered Industrials peers, as of 2026-08-25
- free cash flow (absolute dollars, latest fiscal year)middle range 414 covered Industrials peers, as of FY2026
Position among covered Industrials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
EXPO is not currently in any published Top 10 list. Its scores are below.
Long-term score
52.1 #677 of 1,605 scored · #95 of 274 in Industrials
Financial health 82nd (debt to equity 0, free cash flow margin 18.8%) and profitability 73rd (return on equity 27.9%, operating margin 19.4%); weakest is valuation (27th, price to book 11.7, price to earnings 33).
Short-term score
60.5 #185 of 1,698 scored · #25 of 281 in Industrials
Trend 67th: it is trading 12.1% above its 50-day average, the short-term trend line; momentum 61st: over the past 3 months this stock beat the market by 20.1 percentage points; weakest is setup 56th: a fresh 20-day high.
Scores as of 24 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 3.
Dividend coverage (FY2026)
Covered by reported results. In FY2026, EXPO's dividend was covered by reported results (earnings payout 58%, free-cash-flow payout 50%). This describes past coverage, not a forecast.
- Earnings payout58% dividends / net income
- Free-cash-flow payout50% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2026 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How EXPONENT INC looks technically
EXPONENT INC (EXPO) is trading 5.3% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed below its 200-day average about 103 trading days ago — a "death cross", a bearish long-term signal. A trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 24 (a reading of 25+ marks a strong trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 66, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 4 trading days ago (its momentum flipped positive). It just made a new 20-day high, its first since 2026-03-09, pushing above its recent trading range.
Trend
9
| Distance from the 200-day | it is trading 5.3% above its 200-day average, the long-term trend line — a longer-term uptrend | +5.3% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $63.14 | $63.14 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $67.22 | $67.22 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing high 21 calendar days ago — the swings before that are what the structure reading is measured on | 21 sessions |
| Wave structure | its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that upward direction; the labelling fails if price closes below 65.565. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible upward five-wave sequence, in wave 4 (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 103 trading days ago — a "death cross", a bearish long-term signal | 103 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 5.3% above | +5.3% |
| Trend strength (14-day ADX) | a trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 24 (a reading of 25+ marks a strong trend) | 24.3 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 66, neither overbought (above 70) nor oversold (below 30) | 66.3 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($65.26 to $71.45) — its "stochastic" reading is 89 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 89.2 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 4 trading days ago (its momentum flipped positive) | 4 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $81.92 | $81.92 |
|---|---|---|
| From the 52-week high | it is 13.6% below its 52-week high (its highest price of the past year) | -13.6% |
| Above the 52-week low | it is 36.4% above its 52-week low (its lowest price of the past year) | +36.4% |
| Below the 52-week high | it is 13.6% below its highest point of the past year | 13.6% |
| Since a 20-day breakout | it just made a new 20-day high, its first since 2026-03-09, pushing above its recent trading range | 1 session |
| Since a 55-day breakout | it just made a new 55-day high, its first since 2026-03-09, pushing above its recent trading range | 1 session |
| All-time high | its highest closing price on record is $127.61 (set on 2021-11-22) | $127.61 |
| Given back of the 52-week move | over the past year its closes ranged ($53.67 to $79.79), and it has recovered well over two thirds of its fall from last year’s high — 66% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $69.81 to $70.65. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 65.5% |
| From the all-time high | it is 44.5% below its all-time high | -44.5% |
| Nearest price level | it is trading 0.6% above a support level at $70.37 — a price it turned at twice since 2025-10-22, most recently on 2025-12-09. Since 2024-08-26 it has 5 such levels below the current price and 10 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -0.6% |
| All-time low | its lowest closing price on record is $3.31 (set on 2005-08-12) | $3.31 |
| Above the all-time low | it is 2036.8% above its all-time low | +2,037% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 73% of it) | 27th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $2.05 between its high and its low — about 2.9% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $2.05 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $64.34 and $70.77 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $64.34 – $67.55 – $70.77 |
| Typical daily range (% of price) | its price moves about 2.9% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.9% |
| Stretch from the 200-day average | it is trading 1.7 daily ranges above its 200-day average price (5.3% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 1.7 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.85× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
1
| Since a doji | 7 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 7 sessions ago |
|---|
Price gaps
2
| Gap at the open | it opened on 2026-08-24 0.3% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and had not traded back through that level by the close | +0.3% |
|---|---|---|
| Gap filled | a 2.7% gap up opened on 2026-06-18 has been "filled" 45 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 45 sessions ago |
Price streaks
1
| Closing streak | it has closed higher 2 sessions in a row, a +2.02% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 2 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 11.9 percentage points (the stock gained 15.2% while the market gained 3.3%) | +11.9% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 20.1 percentage points (the stock gained 22.5% while the market gained 2.4%) | +20.1% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 10.2 percentage points (the stock gained 0.8% while the market gained 11.1%) | -10.2% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 20.4 percentage points (the stock lost 2.1% while the market gained 18.3%) | -20.4% |
Signal agreement
2
| Bullish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bullish state: trading above its 200-day average, a fresh 20-day high, MACD momentum is positive, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 9 |
|---|---|---|
| Bearish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, lagging the market over 6 months, near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 3 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 16% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-17 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is thin, spanning 1.2% of the share price, which is taken to mean a barrier that gives way easily. | +15.8% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 8% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $65.24 — a volume-weighted average of daily closes over 158 sessions, not a true tick-by-tick VWAP. | +8.5% |
|---|---|---|
| Vs the average paid since it last reported | the price is 5% above the average price paid since it last reported on 2026-07-30 (its 8-K), so the typical buyer over that stretch is showing a gain. That average is $67.54 — a volume-weighted average of daily closes over 18 sessions, not a true tick-by-tick VWAP. | +4.8% |
Price levels it has turned at before
EXPO last closed at $70.78 on 2026-08-24. Since 2024-08-26 it has turned at 5 prices below its last close and 10 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $70.37 | Support | 0.6% below the last close | turned there twice · 2025-10-22 to 2025-12-09 |
| $68.87 | Support | 2.7% below the last close | turned there 9 times · 2025-08-18 to 2026-08-03 |
| $73.02 | Resistance | 3.2% above the last close | turned there 9 times · 2025-04-07 to 2026-01-14 |
| $75.13 | Resistance | 6.1% above the last close | turned there three times · 2025-05-28 to 2026-03-04 |
| $65.58 | Support | 7.3% below the last close | turned there twice · 2026-02-13 to 2026-07-17 |
| $76.71 | Resistance | 8.4% above the last close | turned there four times · 2025-04-21 to 2026-01-26 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes below $65.56.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
On past moves of this shape the leg has usually ended somewhere between $65.56 and $67.21 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
This reading has stood for 4 trading days, since 2026-08-19.
Read from daily closes as of 2026-08-24.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Tested and reclaimed 200-day support · Broke out to a new 20-day high · MACD just crossed bullish (12/26/9) · lagging the market · At the top of its 14-day range (stochastic above 80) | Learn: moving average · golden cross · adx · rsi · macd · breakout
Based on daily closing prices as of 2026-08-24. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$84.00 range $72.00 – $90.00; median $90.00
Analyst estimates, as of 2026-08-20. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for EXPO
- Consensus EPS estimate$0.6458 next reporting period, as of 2026-08-20
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Dependence on highly skilled professional staff to maintain technical expertise and reputation.","Exposure to potential professional liability claims and litigation arising from consulting services.","Fluctuations in project demand based on client industries and regulatory environments."]
What changed in the latest 10-Q
AI-assisted comparison of EXPO's 10-Q filed 2026-05-08 against the prior one filed 2025-11-07.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing references fiscal year ended January 2, 2026 and 2025 Annual Report filed February 27, 2026 (vs. older filing's January 3, 2025 and February 28, 2025 with April 18, 2025 amendment)
- Newer filing states firm leverages 'over 55 years of experience' (vs. older filing's 'over 50 years')
- Newer filing removes reference to 'physicians' from the description of the interdisciplinary organization
- Newer filing reports Q1 2026 revenue of $166,303,000 (14% increase) with revenues before reimbursements of $151,817,000 (10% increase)
- Newer filing reports Q1 2026 net income of $29,569,000 (11% increase) and diluted EPS of $0.59
- Newer filing discloses negative tax impact from stock-based awards of $896,000 in Q1 2026 vs. $469,000 in Q1 2025
- Newer filing reports Q1 2026 billable hours of 399,000 (6% increase) with 76% utilization (1% increase) and 1,013 technical FTEs (5% increase)
- Newer filing cites 'user research studies for consumer electronics clients integrating artificial intelligence' as revenue driver
- Newer filing cites 'risk management work for utility clients evaluating asset performance under extreme weather conditions' as revenue driver
- Newer filing Engineering and Other Scientific segment: Q1 2026 revenue $141,412,000 (15.8% increase) with 327,000 billable hours (9% increase) and 814 technical FTEs (7% increase)
- Newer filing Environmental and Health segment: Q1 2026 revenue $24,891,000 (6.5% increase) with 72,000 billable hours (5% decrease) and 69% utilization
- Removed:
- Older filing references fiscal year ended January 3, 2025 and 2024 Annual Report filed February 28, 2025 (amended April 18, 2025)
- Older filing's reference to 'physicians' in describing the interdisciplinary organization
- Older filing's disclosure of Q3 2025 results (third quarter of 2025, not Q1 2026)
- Older filing's disclosure of Q3 2025 revenue of $147,120,000 (8% increase) and EPS of $0.55
- Older filing's disclosure of Q3 2025 billable hours of 376,000 with 74% utilization and 976 technical FTEs
- Older filing's details on compensation and related expenses section (text appears truncated before this section in newer filing)
- Reworded:
- Older filing's phrase 'The inclusion of such forward-looking information should not be regarded as a representation by the us' changed to 'by the Company' in newer filing (appears to correct a typo)
- Newer filing's critical accounting estimates section references 'three months ended April 3, 2026' vs. older filing's 'nine months ended October 3, 2025'
- Revenue driver language shifted from older filing's 'Increasing demand for dispute-related work' and 'lower activity in consumer electronics' to newer filing's emphasis on 'user research studies' and 'artificial intelligence' integration
- Notes:
- The newer and older filings present results from different quarters (Q1 2026 vs. Q3 2025), so comparisons are period-specific rather than depicting changes to the same quarter
- The newer filing text appears truncated at the end of the Environmental and Health segment discussion and before compensation expenses section
- All numerical changes reflect different reporting periods and year-over-year comparisons, not accounting policy changes
Risk Factors
- Added:
- Newer filing includes financial statements for three months ended April 3, 2026 and April 4, 2025
- Newer filing balance sheet dates: April 3, 2026 and January 2, 2026
- Newer filing income statement shows miscellaneous loss of $758k (April 3, 2026) vs. miscellaneous loss of $9,386k (April 4, 2025)
- Newer filing comprehensive income shows foreign currency translation adjustment loss of $281k (April 3, 2026) vs. gain of $946k (April 4, 2025)
- Newer filing stockholders' equity table for three months ended April 3, 2026 shows single period presentation
- Newer filing stockholders' equity table for three months ended April 4, 2025 shows single period presentation
- Removed:
- Older filing included financial statements for three and nine months ended October 3, 2025 and September 27, 2024
- Older filing balance sheet dates: October 3, 2025 and January 3, 2025
- Older filing income statement showed miscellaneous income net of $7,267k (three months) and $15,175k (nine months)
- Older filing comprehensive income showed foreign currency translation adjustment gain of $91k (three months) and $1,389k (nine months)
- Older filing stockholders' equity table for three and nine months ended October 3, 2025 with intermediate balance at July 4, 2025
- Older filing stockholders' equity table for three and nine months ended September 27, 2024 with intermediate balance at June 28, 2024
- Reworded:
- Balance sheet comparison periods changed from October 3, 2025/January 3, 2025 to April 3, 2026/January 2, 2026
- Income statement periods changed from October 3, 2025/September 27, 2024 to April 3, 2026/April 4, 2025
- Comprehensive income statement periods changed from October 3, 2025/September 27, 2024 to April 3, 2026/April 4, 2025
- Stockholders' equity statement changed from nine-month periods to three-month periods only
- Notes:
- The newer filing appears to be truncated (cash flows statement incomplete), limiting full comparison
- Older filing included both three-month and nine-month comparative data; newer filing shows only three-month data
- Financial statement comparison is between different fiscal quarters (Q1 2026 vs. Q3 2025 in older filing)
- Risk Factors section page numbers differ (27 vs. 31) but underlying Risk Factors content not provided for comparison
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 3 open-market sales by insiders in the last 90 days.
- Last 90 days0 buys · 3 sells ($344348) — 1 selling insider
- Last 180 days0 buys · 13 sells ($2M) — 5 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-07-15. As of 2026-08-26.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about EXPO's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Congressional trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 5 matched disclosures for EXPO from U.S. House Clerk Periodic Transaction Report filings.
Congressional trading disclosures →Institutional ownership (13F)
5 institutional 13F filers reported holding EXPO as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 8,118,073
- Reported value $529,704,301
reported quarterly holdings change (2025-12-31 → 2026-03-31): 1 new, 2 increased, 2 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
EXPO had 2,978,528 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
EXPO had 6.26% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 4.64 days to cover at the same settlement.
- Reported short interest (shares) 2,978,528
- Short interest (% of shares outstanding) 6.26%
- Prior settlement (shares) 2,929,444
- Reported change 1.68%
- Days to cover (reported) 4.64
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Tetra Tech (TTEK)
- Jacobs Solutions (J)
- AECOM (ACM)
- Stantec (STN)
- FTI Consulting (FCN)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare EXPO vs…
Frequently asked questions
What does EXPONENT INC (EXPO) do?
Exponent is a multi-disciplinary engineering and scientific consulting firm that provides solutions for complex technical, regulatory, and business problems. The company serves clients by investigating failures, assessing risks, and providing research and development support across diverse industries. Its professional staff comprises hundreds of scientists and engineers with expertise in various technical disciplines.
What sector is EXPONENT INC (EXPO) in?
EXPONENT INC (EXPO) is classified in the Industrials sector. Its industry is Technical and Engineering Consulting. It trades on NASDAQ.
Does EXPO pay a dividend?
Yes — EXPONENT INC (EXPO) pays a dividend, with an indicated yield of about 1.34% and at least 2 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-08-25). Informational only — not financial advice.
Who are EXPONENT INC's (EXPO) competitors?
Notable peers of EXPONENT INC (EXPO) include Tetra Tech, Jacobs Solutions, AECOM, Stantec and FTI Consulting. This peer set is informational only — not financial advice.
Has there been recent Congressional stock trading in EXPO?
Yes — we hold 5 matched STOCK Act disclosures for EXPO from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is EXPONENT INC (EXPO) overbought or oversold right now?
EXPONENT INC (EXPO) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 66, in the neutral middle (as of 2026-08-24). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on EXPO come from?
Fundamentals and prices come from market data, as of 2026-08-25; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-25. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-24.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.